Cablivi
caplacizumab · KIT · Genzyme Corporation
No Recall History
Plain English
Cablivi is a kit containing caplacizumab. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- Cablivi
- Generic Name
- caplacizumab
- NDC Code (Product)
58468-0225- Manufacturer
- Genzyme Corporation
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761112
- Marketing Start
- 02/06/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Cablivi used for?
Cablivi contains caplacizumab. It is a kit taken as directed. Consult your doctor for specific uses.
Is Cablivi a controlled substance?
Cablivi is not classified as a controlled substance by the DEA.
What is the generic name for Cablivi?
The generic name for Cablivi is caplacizumab. There are no other listed brand versions of caplacizumab.
What is the NDC code for Cablivi ?
The NDC (National Drug Code) for Cablivi is 58468-0225, listed by Genzyme Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)